Skip to content

Efficacy of surgical excision and subdermal injection of triamcinolone acetonide for treatment of keloid scars after caesarean section

Efficacy of surgical excision and subdermal injection of triamcinolone acetonide for treatment of keloid scars after caesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202111568106591
Enrollment
54
Registered
2021-11-29
Start date
2021-12-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

control group
study group

Sponsors

suez canal university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: age between18–45 years old; (2) being pregnant at the time of recruitment; (3) presence of a keloid scar from a previous caesarean section; ( 4) planned caesarean section for the current pregnancy. Women of all ethnicities with a keloid scar following a previous caesarean section will be eligible to participate in the study.

Exclusion criteria

Exclusion criteria: having a previous caesarean section with no keloid scar.

Design outcomes

Primary

MeasureTime frame
To determine efficacy of Surgical excision and subdermal injection of triamcinolone acetonide for prevention of keloid scars after caesarean section . 2- To asses side effects of the surgical excision and subdermal injection of triamcinolone acetonide at the time of caesarean section (recent scar)

Secondary

MeasureTime frame
To evaluate the effect of surgical excision and subdermal injection of triamcinolone acetonide on symptoms of depression in women with keloid scars . 2-To investigate patients ‘satisfaction with the treatment and their perception with the changes in their keloid scar after surgical excision and subdermal injection of triamcinolone acetonide .

Countries

Egypt

Contacts

Public Contactomima taha

suez canal university

omimatharwat@yahoo.com01223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026